Stay updated with breaking news from Nasdaq tenx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Rating) – Equities research analysts at Zacks Small Cap issued their Q2 2023 earnings per share estimates for shares of Tenax Therapeutics in a research note issued to investors on Monday, May 22nd. Zacks Small Cap analyst J. Vandermosten expects that the specialty pharmaceutical company will post earnings per […] ....
Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Rating) saw a significant decline in short interest in April. As of April 15th, there was short interest totalling 198,800 shares, a decline of 13.6% from the March 31st total of 230,000 shares. Based on an average daily volume of 4,050,000 shares, the days-to-cover ratio is currently 0.0 days. […] ....
Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Rating) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 230,000 shares, a decrease of 89.4% from the March 15th total of 2,160,000 shares. Approximately 2.6% of the company’s shares are sold short. Based […] ....
Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Rating) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 230,000 shares, a decline of 89.4% from the March 15th total of 2,160,000 shares. Currently, 2.6% of the company’s stock are sold short. Based on an average […] ....
Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Rating) saw a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 230,000 shares, a decrease of 89.4% from the March 15th total of 2,160,000 shares. Approximately 2.6% of the company’s shares are short sold. Based on an average […] ....